Aurigene Oncology Limited announces promising results of Phase 1 study for India’s first trial for novel autologous CAR-T cell therapy for multiple myeloma
Bengaluru & Hyderabad, India; October 8, 2024: Aurigene Oncology Limited, a wholly-owned subsidiary of Dr. Reddy’s Laboratories Limited and a clinical stage biotech committed to bringing in novel and effective therapeutics for the treatment of cancer, has announced the Phase 1 results for Ribrecabtagene autoleucel (DRL-1801) from the SWASTH study – India’s first trial for a novel autologous […]
Dr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries
Hyderabad India; October 2, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), today announced that it has entered into a royalty-free non-exclusive voluntary licensing agreement with Gilead Sciences Ireland UC for the manufacture and commercialisation of the drug, Lenacapavir, in India and 120 […]
RedSail Technologies Partners with NationsBenefits® Bringing Advanced Member Care and Improved Efficiencies to Over 6000 Independent Pharmacies Nationwide
RedSail Technologies Partners with NationsBenefits® Bringing Advanced Member Care and Improved Efficiencies to Over 6000 Independent Pharmacies Nationwide RedSail Technologies and NationsBenefits Expand OTC Access for Medicare Advantage and Medicaid Members (Spartanburg, SC – 10/1/2024) NationsBenefits, the market leader in supplemental benefits and healthcare fintech solutions, today announced a new partnership with RedSail Technologies, owner […]
Modular Devices Welcomes Dan Dernbach as Senior Vice President of Cleanroom Operations
INDIANAPOLIS–Modular Devices, a leading provider of mobile and modular cleanroom and medical imaging solutions, is excited to announce the appointment of Dan Dernbach as Senior Vice President of Cleanroom Operations. Dan brings a wealth of leadership experience from the biotech, biopharma, and advanced manufacturing sectors and is known for his expertise in cleanroom design, construction, […]
RedSail Technologies® Announces Integration Between Axys® and RTasks to Enhance Medication Management for Assisted Living and Group Homes
(Spartanburg, SC – 9/17/2024) RedSail Technologies, LLC, the developer of Axys, is excited to announce its new integration with RTasks, a web-based Electronic Health Record (EHR) solution specifically designed for assisted living facilities and group homes. This integration is a significant milestone for RedSail Technologies, demonstrating its commitment to transforming care by enabling long-term care […]
14th Annual FrameworkLTC User Conference Set to Accelerate Innovation in Long-Term Care Pharmacy
Pittsburgh, PA – September 13, 2024 – SoftWriters is excited to announce that the 14th Annual FrameworkLTC User Conference will take place from October 8-10, 2024, at the ARIA in Las Vegas. This premier event will bring together leaders in the long-term care pharmacy space to explore the future of pharmacy technology, engage in impactful sessions, and network with […]
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
• Dexcom CGM is being worn by astronauts in space as part of the Polaris Dawn mission, which aims to better understand the effects of spaceflight on human health SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring […]
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Update on the USFDA inspection at the Company’s API manufacturing facility (CTO-6) in Srikakulam, Andhra Pradesh
September 06, 2024 National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ) BSE Limited (Scrip Code: 500124) New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd (Stock Code: DRREDDY) Dear Sir/Madam, Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Update on the USFDA inspection at the Company’s […]
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
June 24, 2024 PARSIPPANY, N.J., June 24, 2024 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, presented two abstracts at the American Diabetes Association’s 84 th Scientific Sessions that point to the potential for adults with type 2 diabetes (T2D) to better manage insulin delivery […]
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
September 3, 2024 • While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently on the market were designed for people living with T1D. • 300-unit insulin reservoir is more suitable for people with T2D who are interested in moving from multiple daily injections (MDI) to pump […]
